Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...
Pat McAfee: "This is now reaching different levels.. This situation between Giannis and the Bucks was a lot more sheltered in ...
Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results